Detalhe da pesquisa
1.
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.
Rheumatology (Oxford)
; 62(7): 2483-2491, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413079
2.
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement.
Clin Exp Rheumatol
; 37(4): 575-584, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30557127
3.
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
Clin Exp Rheumatol
; 36(1): 44-49, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770709
4.
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis.
Rheumatology (Oxford)
; 56(6): 922-927, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28160007
5.
Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
Clin Exp Rheumatol
; 35(5): 804-809, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770712
6.
Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis.
Clin Exp Rheumatol
; 35(5): 772-776, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281459
7.
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
Clin Exp Rheumatol
; 35(4): 660-665, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28516879
8.
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study.
Mod Rheumatol
; 25(5): 724-30, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736361
9.
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.
Ann Rheum Dis
; 73(4): 716-21, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505228
10.
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Arthritis Rheum
; 65(1): 88-97, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23001900
11.
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
Ann Rheum Dis
; 72(7): 1217-20, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23253926
12.
Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).
Clin Exp Rheumatol
; 31(3): 341-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380023
13.
Chlamydophila psittaci subclinical infection in chronic polyarthritis.
Clin Exp Rheumatol
; 29(6): 977-82, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22153301
14.
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response.
J Clin Med
; 10(2)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466837
15.
Iloprost modulates the immune response in systemic sclerosis.
BMC Immunol
; 11: 62, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21159177
16.
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Ann Rheum Dis
; 69(10): 1809-15, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551155
17.
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
Autoimmun Rev
; 19(5): 102509, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173513
18.
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Rheumatology (Oxford)
; 48(12): 1557-9, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19789202
19.
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.
Int J Rheum Dis
; 21(2): 422-430, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082659
20.
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis.
Semin Arthritis Rheum
; 47(5): 619-629, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29102157